Header Logo

Peter N Riskind MD, PhD

TitleProfessor Emeritus
InstitutionUMass Chan Medical School
DepartmentNeurology
AddressUMass Memorial Medical Center
119 Belmont Street
Worcester MA 01605
Phone508-856-0011
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentNeurology
    DivisionNeuroimmunology/MS


    Collapse Biography 
    Collapse education and training
    University of Texas, Austin, Austin, TX, United StatesBAPsychology
    Southwestern Medical School, Dallas, TX, United StatesMD
    University of Texas, Dallas, Dallas, TX, United StatesPHDPhysiology & Neuroendocrin

    Collapse Overview 
    Collapse Summary
    The Multiple Sclerosis Clinic participates in many clinical trials to evaluate the effectiveness of a variety of drugs and treatments for MS. Currently it is the site of several different clinical trials involving patients with Relapsing Remitting and Primary Progressive MS. We are involved in trials to prevent the future worsening of MS, and to improve the quality of life of our patients.
    Collapse overview

    Peter Riskind, MD, PhD is a Professor of Clinical Neurology and is the Director of the MS Clinic at UMMHC. He received his MD and PhD from the University of Texas and completed his neurology residency at Massachusetts General Hospital. He was formerly the Chief of the NeuroImmunology Unit at Massachusetts General Hospital and Director of the MS Clinic at Spaulding Rehabilitation Hospital. He specializes in Multiple Sclerosis and related neuroimmunologic disorders and is a member of the Clinical Advisory Board for the Massachusetts Chapter of the National Multiple Sclerosis Society. He is board-certified in Neurology and Psychiatry.

    The Multiple Sclerosis Clinic at UMass Memorial Health Care participatesin many clinical trials to evaluate the effectiveness of a variety of drugs and treatments for MS. Currently itis the site of several different clinical trials involving patients with Relapsing Remitting and Primary Progressive MS. We are involved in trials to prevent the future worsening of MS, and to improve the quality of life of our patients.

    Along with clinical trials, we are also involved in several clinical research studies which are aimed atfinding the cause or causes of the MS. These studies generally require only one clinic visit and may allow family members to participate by donating blood and filling our questionnaires.



    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C. gMS-Classifier1 does not predict disability progression in multiple sclerosis. Mult Scler. 2019 06; 25(7):1010-1011. PMID: 30168749.
      Citations:    Fields:    Translation:Humans
    2. Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. The varieties of psychosis in multiple sclerosis: A systematic review of cases. Mult Scler Relat Disord. 2017 Feb; 12:9-14. PMID: 28283114.
      Citations: 12     Fields:    Translation:Humans
    3. Paradas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S. Branching enzyme deficiency: expanding the clinical spectrum. JAMA Neurol. 2014 Jan; 71(1):41-7. PMID: 24248152.
      Citations: 16     Fields:    Translation:Humans
    Riskind's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (25)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _